title: Guanylyl cyclase C as a biomarker in colorectal cancer.
abstract: While histologic assessment of nodes is a component of all colon cancer staging paradigms, approximately 30% of patients with histology-negative nodes (pN0) die of disseminated disease reflected by occult nodal metastases. Undetected metastases are particularly important when considering racial disparities in colon cancer, where black subjects with pN0 disease exhibit the greatest differences in outcomes, with >40% excess mortality. Recently, guanylyl cyclase C (GCC), a protein normally restricted to intestinal cells, but universally expressed by colorectal cancer cells, was validated for detecting occult metastases. Indeed, occult tumor burden across regional lymph nodes estimated by GCC quantitative reverse transcription PCR identifies pN0 patients with near zero risk, and those with >80% risk, of unfavorable outcomes. Disproportionately high occult tumor burden in black patients underlies racial disparities in stage-specific mortality. These studies position the platform encompassing quantification of occult tumor burden by GCC quantitative reverse transcription PCR for translation, as a detect-treat paradigm to reduce racial disparities in colon cancer mortality.
authors: Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, 132 South 10th Street, 1170 Main Philadelphia, PA 19107, USA.
authors: Terry
authors: T
authors: Hyslop
authors: Scott A
authors: SA
authors: Waldman
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D015179:Colorectal Neoplasms / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled / Q000235:genetics / Q000378:metabolism*; D018000:Receptors, Peptide / Q000235:genetics / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; D018000:Receptors, Peptide; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled
references: Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1087-93
references: 9419408
references: Ann Surg. 2007 Oct;246(4):568-75; discussion 575-7
references: 17893493
references: J Clin Pathol. 2010 Jun;63(6):530-7
references: 20498026
references: Cancer Res. 2000 Sep 15;60(18):5151-7
references: 11016642
references: J Clin Oncol. 2004 Aug 15;22(16):3408-19
references: 15199089
references: J Clin Oncol. 2009 Apr 20;27(12):2091-6
references: 19188670
references: Ann Surg Oncol. 2011 Nov;18(12):3261-70
references: 21533822
references: Ann Surg Oncol. 2006 Nov;13(11):1386-92
references: 17009147
references: J Clin Oncol. 2005 Dec 1;23(34):8688-96
references: 16246976
references: J Surg Oncol. 2012 Jul 1;106(1):24-30
references: 22252429
references: Anal Biochem. 2006 Jan 15;348(2):198-208
references: 16336939
references: JAMA. 2009 Feb 18;301(7):745-52
references: 19224751
references: Clin Cancer Res. 2006 Aug 1;12(15):4545-52
references: 16899600
references: CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36
references: 21685461
references: Dis Colon Rectum. 1998 Mar;41(3):310-5
references: 9514425
references: Cancer Res. 2001 Apr 1;61(7):3124-30
references: 11306497
references: Clin Pharmacol Ther. 2007 Oct;82(4):441-7
references: 17687268
references: N Engl J Med. 2004 Dec 30;351(27):2817-26
references: 15591335
references: Biotechnol Healthc. 2007 Feb;4(1):33-42
references: 23397413
references: CA Cancer J Clin. 2004 Nov-Dec;54(6):295-308
references: 15537574
references: Biochem Biophys Res Commun. 2000 Jun 24;273(1):225-30
references: 10873591
references: Diagn Mol Pathol. 2010 Mar;19(1):20-7
references: 20186008
references: Hum Pathol. 2005 Feb;36(2):170-9
references: 15754294
references: J Mol Diagn. 2007 Nov;9(5):563-71
references: 17916603
references: Clin Cancer Res. 2011 May 15;17(10):3293-303
references: 21307149
references: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14827-32
references: 8962140
references: Cancer. 2012 May 1;118(9):2532-40
references: 21887684
references: Am J Public Health. 2010 Oct;100(10):1912-6
references: 20724684
references: Cancer. 2010 Oct 1;116(19):4622-31
references: 20626015
references: J Natl Cancer Inst. 1995 Nov 15;87(22):1686-93
references: 7473817
references: Clin Cancer Res. 2011 May 15;17(10):3053-5
references: 21498396
references: Stat Med. 2007 Dec 30;26(30):5596-611
references: 17968873
references: Dis Colon Rectum. 1999 Feb;42(2):143-54; discussion 154-8
references: 10211489
references: J Surg Oncol. 2007 Dec 15;96(8):671-7
references: 18081169
references: Gastroenterology. 2007 Aug;133(2):599-607
references: 17681179
references: Gastroenterology. 2010 Jan;138(1):241-54
references: 19737566
references: Cancer Res. 2002 Aug 1;62(15):4352-63
references: 12154040
references: N Engl J Med. 2005 Feb 3;352(5):476-87
references: 15689586
references: Lancet. 2010 Mar 20;375(9719):1030-47
references: 20304247
references: Am J Pathol. 2007 Dec;171(6):1847-58
references: 17974601
references: J Clin Epidemiol. 2001 Apr;54(4):359-66
references: 11297886
references: Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1950-62
references: 18708384
references: N Engl J Med. 1998 Jul 23;339(4):223-8
references: 9673300
references: N Engl J Med. 1994 Jul 28;331(4):213-21
references: 8015568
references: Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8549-56
references: 16361536
references: Expert Rev Mol Diagn. 2005 Sep;5(5):701-13
references: 16149873
references: Cancer. 2005 Jul 15;104(2):395-404
references: 15952189
references: Ann Intern Med. 1999 Dec 7;131(11):805-12
references: 10610624
references: J Natl Cancer Inst. 2010 Apr 21;102(8):538-46
references: 20357245
references: J Clin Oncol. 2004 May 1;22(9):1564-71
references: 15051756
references: Clin Pharmacol Ther. 2007 Feb;81(2):153-5
references: 17259939
references: Nat Genet. 2006 May;38(5):540-9
references: 16642018
references: Med Clin North Am. 2005 Jul;89(4):771-93
references: 15925649
references: Cancer. 2005 Aug 1;104(3):629-39
references: 15983985
references: J Clin Oncol. 2006 May 10;24(14):2179-87
references: 16682737